AstraZeneca Q2 Non-GAAP EPS tops expectations by $1.36; reconfirms full-year outlook
AstraZeneca Q2 Non-GAAP EPS tops expectations by $1.36; reconfirms full-year outlook
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AstraZeneca Q2 Non-GAAP EPS tops expectations by $1.36; reconfirms full-year outlook